BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 26053065)

  • 1. Role of EGFR expression levels in the regulation of integrin function by EGF.
    Vial D; McKeown-Longo PJ
    Mol Carcinog; 2016 Jun; 55(6):1118-23. PubMed ID: 26053065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidermal growth factor (EGF) regulates α5β1 integrin activation state in human cancer cell lines through the p90RSK-dependent phosphorylation of filamin A.
    Vial D; McKeown-Longo PJ
    J Biol Chem; 2012 Nov; 287(48):40371-80. PubMed ID: 23007402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrin α5β1 simultaneously controls EGFR-dependent proliferation and Akt-dependent pro-survival signaling in epidermoid carcinoma cells.
    Morozevich GE; Kozlova NI; Ushakova NA; Preobrazhenskaya ME; Berman AE
    Aging (Albany NY); 2012 May; 4(5):368-74. PubMed ID: 22626691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bradykinin B2 receptor interacts with integrin alpha5beta1 to transactivate epidermal growth factor receptor in kidney cells.
    Kramarenko II; Bunni MA; Raymond JR; Garnovskaya MN
    Mol Pharmacol; 2010 Jul; 78(1):126-34. PubMed ID: 20385709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epithelial-mesenchymal transition in cervical cancer: correlation with tumor progression, epidermal growth factor receptor overexpression, and snail up-regulation.
    Lee MY; Chou CY; Tang MJ; Shen MR
    Clin Cancer Res; 2008 Aug; 14(15):4743-50. PubMed ID: 18676743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigallocatechin-3-gallate (EGCG) downregulates EGF-induced MMP-9 in breast cancer cells: involvement of integrin receptor α5β1 in the process.
    Sen T; Chatterjee A
    Eur J Nutr; 2011 Sep; 50(6):465-78. PubMed ID: 21170718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gefitinib induces EGFR and α5β1 integrin co-endocytosis in glioblastoma cells.
    Blandin AF; Cruz Da Silva E; Mercier MC; Glushonkov O; Didier P; Dedieu S; Schneider C; Devy J; Etienne-Selloum N; Dontenwill M; Choulier L; Lehmann M
    Cell Mol Life Sci; 2021 Mar; 78(6):2949-2962. PubMed ID: 33151388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidermal growth factor-induced pyruvate dehydrogenase kinase 1 expression enhances head and neck squamous cell carcinoma metastasis
    Hsu JY; Chang JY; Chang KY; Chang WC; Chen BK
    FASEB J; 2017 Oct; 31(10):4265-4276. PubMed ID: 28596235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrin α5 Suppresses the Phosphorylation of Epidermal Growth Factor Receptor and Its Cellular Signaling of Cell Proliferation via N-Glycosylation.
    Hang Q; Isaji T; Hou S; Im S; Fukuda T; Gu J
    J Biol Chem; 2015 Dec; 290(49):29345-60. PubMed ID: 26483551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ERK(MAPK) activity as a determinant of tumor growth and dormancy; regulation by p38(SAPK).
    Aguirre-Ghiso JA; Estrada Y; Liu D; Ossowski L
    Cancer Res; 2003 Apr; 63(7):1684-95. PubMed ID: 12670923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibody-Drug Conjugate αEGFR-E-P125A Reduces Triple-negative Breast Cancer Vasculogenic Mimicry, Motility, and Metastasis through Inhibition of EGFR, Integrin, and FAK/STAT3 Signaling.
    Sankar AP; Cho HM; Shin SU; Sneh T; Ramakrishnan S; Elledge C; Zhang Y; Das R; Gil-Henn H; Rosenblatt JD
    Cancer Res Commun; 2024 Mar; 4(3):738-756. PubMed ID: 38315147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of the minimal N-glycosylation on integrin α5β1 required for its inhibitory effect on EGFR signaling and cell proliferation.
    Hou S; Hang Q; Isaji T; Fukuda T; Gu J
    Biochem Biophys Res Commun; 2020 Feb; 523(1):226-232. PubMed ID: 31858971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RhoC mediates epidermal growth factor-stimulated migration and invasion in head and neck squamous cell carcinoma.
    Tumur Z; Katebzadeh S; Guerra C; Bhushan L; Alkam T; Henson BS
    Neoplasia; 2015 Jan; 17(1):141-51. PubMed ID: 25622907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calreticulin promotes EGF-induced EMT in pancreatic cancer cells via Integrin/EGFR-ERK/MAPK signaling pathway.
    Sheng W; Chen C; Dong M; Wang G; Zhou J; Song H; Li Y; Zhang J; Ding S
    Cell Death Dis; 2017 Oct; 8(10):e3147. PubMed ID: 29072694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MiR-200 Regulates Epithelial-Mesenchymal Transition in Anaplastic Thyroid Cancer via EGF/EGFR Signaling.
    Xue L; Su D; Li D; Gao W; Yuan R; Pang W
    Cell Biochem Biophys; 2015 May; 72(1):185-90. PubMed ID: 25542369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prolactin modulates phosphorylation, signaling and trafficking of epidermal growth factor receptor in human T47D breast cancer cells.
    Huang Y; Li X; Jiang J; Frank SJ
    Oncogene; 2006 Dec; 25(58):7565-76. PubMed ID: 16785991
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of oligosaccharide changes in alpha5beta1 integrin in a cisplatin-resistant human squamous cell carcinoma cell line.
    Nakahara S; Miyoshi E; Noda K; Ihara S; Gu J; Honke K; Inohara H; Kubo T; Taniguchi N
    Mol Cancer Ther; 2003 Nov; 2(11):1207-14. PubMed ID: 14617794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increase in claudin-2 expression by an EGFR/MEK/ERK/c-Fos pathway in lung adenocarcinoma A549 cells.
    Ikari A; Sato T; Watanabe R; Yamazaki Y; Sugatani J
    Biochim Biophys Acta; 2012 Jun; 1823(6):1110-8. PubMed ID: 22546605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The alpha5beta1 integrin selectively enhances epidermal growth factor signaling to the phosphatidylinositol-3-kinase/Akt pathway in intestinal epithelial cells.
    Lee JW; Juliano RL
    Biochim Biophys Acta; 2002 Jan; 1542(1-3):23-31. PubMed ID: 11853876
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential roles of ERK and Akt pathways in regulation of EGFR-mediated signaling and motility in prostate cancer cells.
    Gan Y; Shi C; Inge L; Hibner M; Balducci J; Huang Y
    Oncogene; 2010 Sep; 29(35):4947-58. PubMed ID: 20562913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.